Unlock stock picks and a broker-level newsfeed that powers Wall Street.
AstraZeneca Stock Nears Buy Point After Long Run In Declining Market
In This Article:
AstraZeneca is Thursday's pick for IBD 50 Growth Stocks To Watch as the biopharmaceutical name is holding up relatively well in a declining market. AstraZeneca stock is nearing a buy point after climbing for seven straight weeks. The biopharmaceutical company develops drugs for cancer, immune, cardiovascular, kidney and rare diseases as well as vaccines.
Terms and Privacy Policy